Ignite Creation Date:
2025-12-24 @ 4:34 PM
Ignite Modification Date:
2026-01-05 @ 6:30 PM
Study NCT ID:
NCT00220766
Status:
COMPLETED
Last Update Posted:
2009-09-25
First Post:
2005-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients
Sponsor:
Grifols Therapeutics LLC
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
100348
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Gerald Klein, MD, Chief Medical Officer, Vice President of Medical and Clinical Affairs
Old Organization:
Talecris Biotherapeutics, Inc.